DOCSLIB.ORG

Supplementary Tables Vfinal.Xlsx

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Tables Vfinal.Xlsx Table S3. Carbon Sources Used in the Nanostring Analysis. Concentration used in Nutrient Median Biofilm Value Figure 3 Key Dextrin 0.065 0.2% soluble fraction Low Melibionic Acid 0.072 Medium Mannan 0.081 High L-Homoserine 0.105 Very High Glycogen 0.120 2 mM Adenosine 0.127 2 mM Methyl Pyruvate 0.131 Mucic Acid 0.132 N-Acetyl-D-Glucosamine 0.138 2 mM Glycil-L-Proline 0.147 L-Alanyl-Glycine 0.149 Inosine 0.153 D-Alanine 0.156 2 mM Oxalic Acid 0.163 3-Methyl-Glucose 0.163 D-Aspartic Acid 0.165 D-Trehalose 0.169 2 mM Glycolic Acid 0.171 2 mM 2-Hydroxy Benzoic Acid 0.174 D-Glucosamine 0.177 2-Deoxy-D-Ribose 0.177 2-Deoxy Adenosine 0.178 Bromo Succinic Acid 0.179 Uridine 0.180 2 mM Pectin 0.180 Sorbic Acid 0.180 Negative Control 0.184 1,2-Propanediol 0.185 a-D-Lactose 0.186 Gelatin 0.186 D,L-a-Glycerol-Phosphate 0.186 Maltotriose 0.186 Glycerol 0.188 Inulin 0.189 Glucuronamide 0.189 N-Acetyl-D-Glucosaminatol 0.189 Lactulose 0.189 M-Inositol 0.190 3-0-b-D-Galactopyranosyl-D-Arabinose 0.191 a-Hydroxy Glutaric Acid-g-Lactone 0.193 a-Methyl-D-Galactoside 0.196 D-Psicose 0.196 L-Fucose 0.196 Succinamic Acid 0.197 D-Sorbitol 0.197 2 mM Dulcitol 0.198 D-Fructose-6-Phosphate 0.198 Sedoheptulosa 0.199 Glyoxylic Acid 0.200 Maltose 0.201 2 mM D-Ribono-1,4-Lactone 0.201 Sucrose 0.201 2 mM D-Melibiose 0.202 Mono Methyl Succinate 0.203 N-Acetyl-b-D-Mannosamine 0.204 p-Hydroxy Phenyl Acetic Acid 0.204 L-Rhamnose 0.205 2 mM D-Cellobiose 0.206 D-Glucuronic Acid 0.207 Adonitol 0.207 b-Methyl-D-Glucoside 0.207 Laminarin 0.208 Acetoacetic Acid 0.208 a-Keto-Glutaric Acid 0.208 D-Serine 0.209 L-Proline 0.210 2 mM m-Hydroxy Phenyl Acetic Acid 0.214 L-Alaninamide 0.216 Pyruvic Acid 0.217 2 mM D-Glucose-1-Phosphate 0.217 D-Lactic Acid Methyl Ester 0.217 Stachyose 0.218 a-Methyl-D-Glucoside 0.219 b-Methyl-D-Glucuronic Acid 0.219 Salicin 0.219 4-Hydroxy Benzoic Acid 0.220 Turanose 0.222 D-Tagatose 0.222 L-Malic Acid 0.222 g-Cyclodextrin 0.223 L-Galactonic Acid-g-Lactone 0.223 Glycil-L-Aspartic Acid 0.224 Lactitol 0.224 Sebacic Acid 0.225 Thymidine 0.225 2 mM D-Galactose 0.225 2 mM d-Amino Valeric Acid 0.225 L-Lactic Acid 0.225 2 mM a-Cyclodextrin 0.226 2,3-Butanone 0.227 L-Alanine 0.227 2 mM D-Melezitose 0.227 Amygdalin 0.228 D,L-Octopamine 0.228 2,3-Butanediol 0.228 Xylitol 0.230 L-Sorbose 0.231 Maltitol 0.232 Formic Acid 0.234 I-Erythritol 0.236 b-Cyclodextrin 0.236 D-Fructose 0.236 2 mM b-Methyl-D-Gactoside 0.237 N-Acetyl-D-Galactosamine 0.237 Glycil-L-Glutamic Acid 0.237 L-Lyxose 0.239 Arbutin 0.240 b-Methyl-D-Xyloside 0.241 2 mM Succinic Acid 0.241 2 mM Phenylalanine 0.243 2 mM a-Methyl-D-Mannoside 0.244 Acetamide 0.244 2 mM Tricarballylic Acid 0.244 b-D-Allose 0.244 D-Raffinose 0.245 D-Mannose 0.245 Gentiobiose 0.246 N-Acetyl-Neuraminic Acid 0.247 Fumaric Acid 0.248 5-Keto-D-Gluconic Acid 0.249 D-Ribose 0.250 2 mM Dihydroxy Acetone 0.250 D-Fucose 0.250 g-Hydroxy Butyric Acid 0.252 N-Acetyl-L-Glutamic Acid 0.253 L-Arabitol 0.253 Palatinose 0.253 Putrescine 0.254 Quinic Acid 0.255 L-Arabinose 0.256 0.20% D-Galacturonic Acid 0.258 L-Pyroglutamic Acid 0.259 3-Hydroxy 2-Butanone 0.259 D,L-Malic Acid 0.259 Chondroitin Sulfate C 0.260 Glycine 0.260 L-Leucine 0.264 L-Glucose 0.265 g-Amino Butyric Acid 0.265 Caproic Acid 0.266 Acetic Acid 0.268 2 mM L-Valine 0.268 2 mM Citramalic Acid 0.274 D,L-Carnitine 0.277 D-Arabinose 0.277 L-Glutamic Acid 0.278 D-Xylose 0.279 Oxalomalic Acid 0.280 Capric Acid 0.281 a-Keto Valeric Acid 0.281 L-Asparagine 0.284 2 mM Citric Acid 0.287 0.40% L-Glutamine 0.289 D-Malic Acid 0.289 Malonic Acid 0.292 L-Aspartic Acid 0.292 D-Saccharic Acid 0.293 2 mM L-Methionine 0.296 2 mM 2-Aminoethanol 0.300 L-Histidine 0.301 L-Tartaric Acid 0.303 D-Threonine 0.305 D-Gluconic Acid 0.306 2 mM Sec-Butylamine 0.310 Propionic Acid 0.312 2 mM b-Hydroxy Butyric Acid 0.317 a-D-Glucose 0.317 Tyramine 0.317 2 mM D-Galactonic Acid-g-Lactone 0.319 D-Glucose-6-Phosphate 0.321 Itaconic Acid 0.325 D-Arabitol 0.325 L-Lysine 0.326 2 mM D-Mannitol 0.328 2 mM L-Serine 0.334 2 mM D-Glucosaminic Acid 0.335 2 mM Phenylethyl-amine 0.335 a-Keto-Butyric Acid 0.338 Butyric Acid 0.342 2 mM L-Threonine 0.347 2 mM Citraconic Acid 0.348 2 mM Hydroxy-L-Proline 0.371 D-Tartaric Acid 0.374 M-Tartaric Acid 0.387 2 mM L-Arginine 0.388 0.40% a-Hydroxy Butyric Acid 0.410 L-Isoleucine 0.426 2 mM L-Ornithine 0.451 2 mM.
Load more

Recommended publications
  • Determining the Effect of Small Doses of Fructose and Its Epimers on Glycemic Control
    Determining the Effect of Small Doses of Fructose and its Epimers on Glycemic Control by Jarvis Clyde Noronha A thesis submitted in conformity with the requirements for the degree of Master of Science Department of Nutritional Sciences University of Toronto © Copyright by Jarvis Clyde Noronha 2017 ii Determining the Effect of Small Doses of Fructose and its Epimers on Glycemic Control Jarvis Clyde Noronha Master of Science Department of Nutritional Sciences University of Toronto 2017 Abstract Given that sugars have emerged as the dominant nutrient of concern in diabetes, there is a need for the development of alternative sweeteners. To assess the role of small doses (5g, 10g) of fructose and allulose on postprandial glucose metabolism, we conducted an acute randomized controlled trial in individuals with type 2 diabetes. We found that small doses of allulose, but not fructose, modestly reduced the postprandial glycemic response to a 75g oral glucose load. To assess whether low-dose (< 50-g/day) fructose and all its epimers (allulose, tagatose and sorbose) lead to sustainable improvements in long-term glycemic control, we conducted a systematic review and meta-analysis of controlled feeding trials. The available evidence suggested that fructose and tagatose led to significant reductions in HbA1c and fasting glucose. Our findings highlight the need for long-term randomized controlled trials to confirm the viability of fructose and its epimers as alternative sweeteners. iii Table of Contents Contents Abstract ...........................................................................................................................
    [Show full text]
  • And Honeydew Sugars with Respect to Their Utilization by the Hymenopteran Parasitoid Cotesia Glomerata F.L
    Journal of Insect Physiology 47 (2001) 1077–1084 www.elsevier.com/locate/jinsphys A comparison of nectar- and honeydew sugars with respect to their utilization by the hymenopteran parasitoid Cotesia glomerata F.L. Wa¨ckers * Institute of Plant Sciences, Applied Entomology, Swiss Federal Institute of Technology (ETH), 8092 Zurich, Switzerland Received 10 October 2000; received in revised form 12 February 2001; accepted 19 February 2001 Abstract Fourteen naturally occurring sugars were individually tested with respect to their effect on Cotesia glomerata longevity. Parasitoids kept with solutions of either sucrose, glucose and fructose lived for Ͼ30 days. This constitutes a factor 15 increase in life span in comparison to control individuals kept with water only. Stachyose, mannose, melezitose, melibiose, maltose and erlose increased parasitoid longevity by a factor of 11.2–6.9. Solutions of galactose and trehalose had a marginal, but still significant effect. Lactose and raffinose did not raise parasitoid longevity, while rhamnose actually reduced parasitoid survival. In an additional experiment, the relationship between quantity of sugar consumption and longevity was established for all 14 sugars. To study the effect of an unsuitable sugar in sugar mixtures, a range of glucose:rhamnose mixtures was tested. Even at 20% of the sugar mixture rhamnose suppressed the nutritional benefit of the 80% glucose. The nutritional suitability of the sugars shows a positive correlation with the previously reported gustatory response towards the individual sugars. Patterns of sugar utilization are discussed with respect to hydrolytic enzymes and carbohydrate biochemical characteristics. Our findings for C. glomerata are compared to patterns of sugar utilization reported for other species.
    [Show full text]
  • Electronic Supplementary Information
    Electronic Supplementary Material (ESI) for Chemical Science. This journal is © The Royal Society of Chemistry 2019 Electronic Supplementary Information Poly(ionic liquid)s as a Distinct Receptor Material to Create Highly- Integrated Sensing Platform for Efficiently Identifying a Myriad of Saccharides Wanlin Zhang, Yao Li, Yun Liang, Ning Gao, Chengcheng Liu, Shiqiang Wang, Xianpeng Yin, and Guangtao Li* *Corresponding authors: Guangtao Li ([email protected]) S1 Contents 1. Experimental Section (Page S4-S6) Materials and Characterization (Page S4) Experimental Details (Page S4-S6) 2. Figures and Tables (Page S7-S40) Fig. S1 SEM image of silica colloidal crystal spheres and PIL inverse opal spheres. (Page S7) Fig. S2 Adsorption isotherm of PIL inverse opal. (Page S7) Fig. S3 Dynamic mechanical analysis and thermal gravimetric analysis of PIL materials. (Page S7) Fig. S4 Chemical structures of 23 saccharides. (Page S8) Fig. S5 The counteranion exchange of PIL photonic spheres from Br- to DCA. (Page S9) Fig. S6 Reflection and emission spectra of spheres for saccharides. (Page S9) Table S1 The jack-knifed classification on single-sphere array for 23 saccharides. (Page S10) Fig. S7 Lower detection concentration at 10 mM of the single-sphere array. (Page S11) Fig. S8 Lower detection concentration at 1 mM of the single-sphere array. (Page S12) Fig. S9 PIL sphere exhibiting great pH robustness within the biological pH range. (Page S12) Fig. S10 Exploring the tolerance of PIL spheres to different conditions. (Page S13) Fig. S11 Exploring the reusability of PIL spheres. (Page S14) Fig. S12 Responses of spheres to sugar alcohols. (Page S15) Fig.
    [Show full text]
  • FDA Finalizes Allulose Guidance and Requests Information on Other Sugars Metabolized Differently Than Traditional Sugars
    FDA Finalizes Allulose Guidance and Requests Information on Other Sugars Metabolized Differently Than Traditional Sugars October 19, 2020 Food, Drug, and Device FDA has taken two notable actions regarding the sugars declaration in the Nutrition Facts Label (NFL) and Supplement Facts Label (SFL). On Friday, the agency released a final guidance regarding the declaration of allulose, confirming that this monosaccharide need not be included in the declaration of “Total Sugars” or “Added Sugars,” though it must be included in the “Total Carbohydrates” declaration in the NFL. Today, FDA published a Federal Register notice requesting information about and comments on the nutrition labeling of other sugars that are metabolized differently than traditional sugars. We briefly summarize both documents below to help inform stakeholder comments on the notice, which are due to FDA by December 18, 2020. Allulose Final Guidance Allulose, or D-psicose, is a monosaccharide that can be used as a substitute for traditional sugar in food and beverage products. For purposes of nutrition labeling, FDA has generally 1 defined nutrients based on their chemical structure.0F Accordingly, when FDA updated its NFL and SFL regulations in 2016, the agency reiterated the definition of “Total Sugars” as the sum of 2 all free monosaccharides and disaccharides (e.g. glucose, fructose, and sucrose).1F FDA also added to these regulations a definition of “Added Sugars” – sugars added during the processing 3 of food, or packaged as such – and required their declaration in the NFL and SFL.2F Although the agency recognized that there are sugars that are metabolized differently than traditional sugars, FDA did not make a determination at that time as to whether allulose should be excluded from “Total Carbohydrate,” “Total Sugars,” or “Added Sugars” Declarations.
    [Show full text]
  • Effects of D-Allulose on Glucose Tolerance and Insulin Response to A
    Clinical care/Education/Nutrition Open access Original research BMJ Open Diab Res Care: first published as 10.1136/bmjdrc-2020-001939 on 26 February 2021. Downloaded from Effects of D- allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover study Francesco Franchi ,1 Dmitry M Yaranov,1 Fabiana Rollini,1 Andrea Rivas,1 Jose Rivas Rios,1 Latonya Been,1 Yuma Tani,2 Masaaki Tokuda,3 Tetsuo Iida,2 Noriko Hayashi,2 Dominick J Angiolillo,1 Arshag D Mooradian1 To cite: Franchi F, Yaranov DM, ABSTRACT Rollini F, et al. Effects of D- Introduction Current dietary guidelines recommend Significance of this study allulose on glucose tolerance limiting sugar intake for the prevention of diabetes and insulin response to a mellitus (DM). Reduction in sugar intake may require sugar What is already known about this subject? standard oral sucrose load: substitutes. Among these, D- allulose is a non- calorie rare ► D- allulose is defined one of the rare sugars, results of a prospective, which has been shown in animal and clinical randomized, crossover study. monosaccharide with 70% sweetness of sucrose, which has shown anti- DM effects in Asian populations. However, studies, conducted mostly in Asian populations, BMJ Open Diab Res Care to have postprandial plasma glucose suppres- 2021;9:e001939. doi:10.1136/ there is limited data on the effects of D- allulose in other sive effects with antiobesity and antidiabetic bmjdrc-2020-001939 populations, including Westerners. Research design and methods This was a prospective, effects. copyright. randomized, double- blind, placebo- controlled, crossover What are the new findings? ► Supplemental material is study conducted in 30 subjects without DM.
    [Show full text]
  • Determination of Carbohydrates in Honey Manali Aggrawal, Jingli Hu and Jeff Rohrer, Thermo Fisher Scientific, Sunnyvale, CA
    Determination of carbohydrates in honey Manali Aggrawal, Jingli Hu and Jeff Rohrer, Thermo Fisher Scientific, Sunnyvale, CA ABSTRACT RESULTS SAMPLE ANALYSIS METHOD ACCURACY Table 7. Adulteration parameters for HS6 adulterated with 10% SS1 through SS5. Purpose: To develop an HPAE-PAD method for the determination of carbohydrates in honey Honey sugar analysis Sample Recovery HS6 (Wild Mountain Honey) samples to evaluate their quality and to assess the possibility of adulteration. Separation Adulteration Honey sugars were separated using a Dionex CarboPac PA210-Fast-4μm column (150 × 4 mm) in Method accuracy was evaluated by measuring recoveries of 10 sugar standards spiked into honey Parameters 100% + 10% + 10% + 10% + 10% + 10% For this study, we purchased 12 commercial honey samples (Table 1) and analyzed them using Honey SS1 SS2 SS3 SS4 SS5 Methods: Separation of individual honey sugars was achieved on the recently introduced Thermo series with a Dionex CarboPac PA210 guard column (50 × 4 mm). The column selectivity allow samples. For spiking experiments, four honey samples were used (HS7–HS10) and spiked with a 10- HPAE-PAD. Figure 3 shows the representative chromatograms of 3 honey samples. For all 12 Glucose(G), mg/L 121 115 116 117 119 107 Scientific™ Dionex™ CarboPac™ PA210-Fast-4μm column. Carbohydrate detection was by pulsed carbohydrates to be separated with only a hydroxide eluent generated using an eluent generator. A sugar standard mix at two concentration levels. Figure 4 shows the representative chromatograms investigated honey samples, fructose and glucose (Peak 2 and Peak 3), were found to be the major Fructose(F), mg/L 127 115 115 116 126 116 amperometric detection (PAD) with a gold working electrode and, therefore, no sample derivatization solution of honey sugar standards was prepared and an aliquot (10 μL) of the solution was injected of unspiked and spiked honey sample HS7.
    [Show full text]
  • Natural Alternative Sweeteners and Diabetes Management
    Current Diabetes Reports (2019) 19:142 https://doi.org/10.1007/s11892-019-1273-8 LIFESTYLE MANAGEMENT TO REDUCE DIABETES/CARDIOVASCULAR RISK (B CONWAY AND H KEENAN, SECTION EDITORS) Natural Alternative Sweeteners and Diabetes Management Emily Mejia1 & Michelle Pearlman2 # Springer Science+Business Media, LLC, part of Springer Nature 2019 Abstract Purpose of Review The goal of this review is to discuss the data on natural alternative sweeteners and their effects on glucose homeostasis and other metabolic parameters within the past five years. We sought to answer whether common natural alternative sweeteners have a positive or negative effect on glucose control in both human and animal models, and whether the data supports their widespread use as a tool to help reduce the prevalence of diabetes and associated comorbid conditions. Recent Findings Recent studies suggest that natural alternative sweeteners may reduce hyperglycemia, improve lipid metabo- lism, and have antioxidant effects particularly in those that have baseline diabetes. Summary Diabetes and metabolic syndrome have become a global healthcare crisis and the sugar overconsumption plays a major role. The use of artificial sweeteners has become more prevalent to improve insulin resistance in those with diabetes, obesity, and metabolic syndrome, although the evidence does not support this result. There are however some promising data to suggest that natural alternative sweeteners may be a better alternative to sugar and artificial sweeteners. Keywords Natural alternative sweeteners . Diabetes . Stevia . Sugar alcohols . Rare sugars Introduction retinopathy, nephropathy, cerebrovascular disease, peripheral vascular disease, and cardiovascular disease [2–4]. Type 2 Diabetes mellitus (DM) is a metabolic disorder that results DM (T2DM) often coexists with other metabolic disorders from glucose dysregulation.
    [Show full text]
  • Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism
    nutrients Review Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism Hideya Shintani 1 , Tomoya Shintani 2,* , Hisashi Ashida 3 and Masashi Sato 4 1 Department of Internal Medicine, Saiseikai Izuo Hospital, Osaka 551-0032, Japan; [email protected] 2 United Graduate School of Agricultural Science, Ehime University, Matsuyama 790-8577, Japan 3 Faculty of Biology-Oriented Science and Technology, Kindai University, Wakayama 649-6493, Japan; [email protected] 4 Faculty of Agriculture, Kagawa University, Kagawa 761-0701, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-6-6621-5122 Received: 6 November 2018; Accepted: 18 November 2018; Published: 22 November 2018 Abstract: Calorie restriction (CR) can prolong the human lifespan, but enforcing long-term CR is difficult. Therefore, a compound that reproduces the effect of CR without CR is needed. In this review, we summarize the current knowledge on compounds with CR mimetic (CRM) effects. More than 10 compounds have been listed as CRMs, some of which are conventionally categorized as upstream-type CRMs showing glycolytic inhibition, while the others are categorized as downstream-type CRMs that regulate or genetically modulate intracellular signaling proteins. Among these, we focus on upstream-type CRMs and propose their classification as compounds with energy metabolism inhibition effects, particularly glucose metabolism modulation effects. The upstream-type CRMs reviewed include chitosan, acarbose, sodium-glucose cotransporter 2 inhibitors, and hexose analogs such as 2-deoxy-D-glucose, D-glucosamine, and D-allulose, which show antiaging and longevity effects. Finally, we discuss the molecular definition of upstream-type CRMs.
    [Show full text]
  • D-Allulose Is a Substrate of Glucose Transporter Type 5 (GLUT5) in the Small Intestine
    Food Chemistry 277 (2019) 604–608 Contents lists available at ScienceDirect Food Chemistry journal homepage: www.elsevier.com/locate/foodchem D-Allulose is a substrate of glucose transporter type 5 (GLUT5) in the small intestine T ⁎ Kunihiro Kishidaa, , Gustavo Martinezb, Tetsuo Iidac, Takako Yamadac, Ronaldo P. Ferrarisb,1, Yukiyasu Toyodad,1 a Department of Science and Technology on Food Safety, Kindai University, 930 Nishimitani, Kinokawa, Wakayama 649-6493, Japan b Department of Pharmacology, Physiology, and Neurosciences, New Jersey Medical School, Rutgers University, 185 S. Orange Avenue, Newark, NJ 07101-1749, USA c Research and Development, Matsutani Chemical Industry Company, Limited, 5-3 Kita-Itami, Itami, Hyogo 664-8508, Japan d Department of Pathobiochemistry, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya, Aichi 468-8503, Japan ARTICLE INFO ABSTRACT Keywords: D-Allulose has been reported to have beneficial health effects. However, the transport system(s) mediating in- D-Allulose testinal D-allulose transport has not yet been clearly identified. The aim of this study was to investigate whether Intestinal absorption intestinal D-allulose transport is mediated by glucose transporter type 5 (GLUT5). When D-allulose alone was GLUT5 gavaged, plasma D-allulose levels were dramatically higher in rats previously fed fructose. This suggests en- hanced intestinal D-allulose absorption paralleled increases in GLUT5 expression observed only in fructose-fed rats. When D-allulose was gavaged with D-fructose, previously observed increases in plasma D-allulose levels were dampened and delayed, indicating D-fructose inhibited transepithelial D-allulose transport into plasma. Tracer D- 14 [ C]-fructose uptake rate was reduced to 54.8% in 50 mM D-allulose and to 16.4% in 50 mM D-fructose, sug- 14 gesting D-allulose competed with D-[ C]-fructose and the affinity of D-allulose for GLUT5 was lower than that of D-fructose.
    [Show full text]
  • GRAS Notifications to FDA – a Review of Ingredients with Intended Use In
    GRAS Ingredients for Use in Medical Foods GRAS Ingredients for Use in Medical Foods: An Overview of FDA Regulation Ginny Bank, Cheryl Dicks, MS, RAC 1 © GRAS Associates 2016 www.gras-associates.com GRAS Ingredients for Use in Medical Foods Contents Introduction ..................................................................................................... 3 FDA Medical Food Regulation Overview ........................................................ 4 GRAS Notifications to FDA – A Review of Ingredients with Intended Use in Medical Foods ................................................................................................. 6 Ready to seek GRAS status for your medical food ingredient? ................. 11 Regulatory Services Include: ..................................................................... 11 Uncover greater market opportunities for your ingredient ......................... 12 Contact GRAS Associates today ............................................................... 12 Appendix A – Summary of GRAS Notifications Submitted to FDA for Ingredients Intended for Use in Medical Foods .......................................... 13 2 © GRAS Associates 2016 www.gras-associates.com GRAS Ingredients for Use in Medical Foods Introduction The medical food arena is a growing specialty product category that presents food and dietary supplement manufactures with interesting business opportunities for market expansion of an ingredient or final product. The Business Insights: The Emerging Market for Medical Foods Nutraceuticals
    [Show full text]
  • D-Psicose Nutrasource, Inc.Inc
    ORIGINAL SUBMISSION 000001 GRAS exemption claim for D-psicose NutraSource, Inc.Inc. August 18,18, 20112011 Dr. Susan CarlsonCarlson Division ofof BiotechnologyBiotechnology andand GRASGRAS NoticeNotice ReviewReview Office of Food AdditiveAdditive Safety-CFSANSafety-CFSAN U.S. Food andand DrugDrug AdministrationAdministration 5100 Paint Branch ParkwayParkway (HFS-255)(HFS-255) College Park, MDMD 20740-383520740-3835 DiVisionDivision of BiotechnologyBiotechnology and GRAS Notice ReviewReview Re: GRAS exemption claimclaim forfor D-psicoseD-psicose asas anan ingredientingredient inin foodsfoods Dear Dr. Carlson,Carlson, This is to notify you that CJCJ CheiljedangCheiljedang (based(based inin S.S. Korea)Korea) claimsclaims thatthat thethe useuse ofof thethe substance described below (D-psicose) is exempt fromfrom the the premarketpremarket approvalapproval requirementsrequirements ofof the Federal Food, Drug, and CosmeticCosmetic ActAct becausebecause CJCJ AmericaAmerica hashas determineddetermined suchsuch useuse toto bebe Generally Recognized AsAs SafeSafe (GRAS).(GRAS). On behalf ofCJof CJ Cheiljedang, NutraSource (an independent consultingconsulting firm)firm) assembledassembled aa panel of experts highly qualified byby scientificscientific trainingtraining andand experienceexperience toto evaluateevaluate thethe safetysafety ofof the intended uses ofofD-psicose. D-psicose. The panel includedincluded Dr.Dr. SusanSusan ChoCho atat NutraSourceNutraSource (Clarksville,(Clarksville, MD), Dr. Joanne Slavin (The University ofof Minnesota,Minnesota,
    [Show full text]
  • Potent Inhibitory Effects of D-Tagatose on the Acid Production and Water-Insoluble Glucan Synthesis of Streptococcus Mutans GS5 in the Presence of Sucrose
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Okayama University Scientific Achievement Repository Acta Med. Okayama, 2015 Vol. 69, No. 2, pp. 105ﾝ111 CopyrightⒸ 2015 by Okayama University Medical School. Original Article http ://escholarship.lib.okayama-u.ac.jp/amo/ Potent Inhibitory Effects of D-tagatose on the Acid Production and Water-insoluble Glucan Synthesis of Streptococcus mutans GS5 in the Presence of Sucrose Daijo Sawadaa,b＊, Takaaki Ogawaa, Minoru Miyakea, Yoshinori Hasuib, Fuminori Yamaguchic, Ken Izumorid, and Masaaki Tokudac,d Departments of aOral and Maxillofacial Surgery and cCell Physiology, Faculty of Medicine, Kagawa University, Miki, Kagawa 761-0793, Japan, bHasui Dental Family Clinic, Kagawa 761-0704, Japan, dRare Sugar Research Center, Miki, Kagawa 761-0793, Japan We examined and compared the inhibitory effects of D-tagatose on the growth, acid production, and water-insoluble glucan synthesis of GS5, a bacterial strain of Streptococcus mutans, with those of xylitol, D-psicose, L-psicose and L-tagatose. GS5 was cultured for 12h in a medium containing 10ｵ (w/v) of xylitol, D-psicose, L-psicose, D-tagatose or L-tagatose, and the inhibitory effect of GS5 growth was assessed. Each sugar showed different inhibitory effects on GS5. Both D-tagatose and xylitol significantly inhibited the acid production and water-insoluble glucan synthesis of GS5 in the presence of 1ｵ (w/v) sucrose. However, the inhibitory effect of acid production by D-tagatose was significantly stronger than that of xylitol in presence of sucrose. Key words: Streptococcus mutans, D-tagatose, xylitol, acid production, water-insoluble glucan he definition of ʻrare sugarsʼ is monosaccha- the most extensively examined rare sugar, including T raides and their derivatives that are not com- anti-diabetes and anti-obesity effects [4-7].
    [Show full text]